BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11745919)

  • 1. Folinic acid protects against suppression of growth by methotrexate in mice.
    Iqbal MP; Sultana F; Mehboobali N; Pervez S
    Biopharm Drug Dispos; 2001 May; 22(4):169-78. PubMed ID: 11745919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of indomethacin and methotrexate on suppression of growth in rats.
    Iqbal MP; Saeed SA; Pertani S; Mehboobali N
    Biopharm Drug Dispos; 1999 Nov; 20(8):389-95. PubMed ID: 10870096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methotrexate and folinic acid on skeletal growth in mice.
    Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
    Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methotrexate and folinic acid on accumulation of iron in mice.
    Iqbal MP; Mehboobali N; Sultana F; Khan FB; Burney IA; Kakepoto GN
    Med Hypotheses; 2003 Oct; 61(4):444-5. PubMed ID: 13679009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
    Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A
    Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.
    Kruger-McDermott C; Balinska M; Galivan J
    Cancer Lett; 1986 Jan; 30(1):79-84. PubMed ID: 3484673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
    Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
    Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
    Boarman DM; Baram J; Allegra CJ
    Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate inhibition of bone mineral density increase in growing rabbits: prevention by folinic acid.
    Laurindo IM; Mendes FL; Novaes GS; Mello SB; Falco V; Jorgetti V
    Clin Exp Rheumatol; 2003; 21(5):581-6. PubMed ID: 14611105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
    Rosenblatt DS; Whitehead VM; Matiaszuk NV; Pottier A; Vuchich MJ; Beaulieu D
    Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc Supplementation Alone Is Effective for Partial Amelioration of Methotrexate-induced Intestinal Damage.
    Musa NS; Howarth GS; Tran CD
    Altern Ther Health Med; 2015; 21 Suppl 2():22-31. PubMed ID: 26308757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
    Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
    Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
    DeSesso JM; Goeringer GC
    Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the antifolate drug Methotrexate on the development of murine neural tube defects and genomic instability.
    Zhao J; Guan T; Wang J; Xiang Q; Wang M; Wang X; Guan Z; Xie Q; Niu B; Zhang T
    J Appl Toxicol; 2013 Sep; 33(9):915-23. PubMed ID: 22806879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.